CVS Corp CVS

$90.25 -0.08 (-0.09%)

Valuation

Market cap
115,427,040,000
Revenue TTM
$402,067,000,000
Net income TTM
$1,768,000,000
P/E (trailing)
11.52
P/E (forward)
11.26
Profit margin
0.44%
Debt to equity
0.77

Trading

Volume
8,187,700
Avg volume
7,780,574
Day's range
$89.90 – $91.95
Shares out
1,278,970,000
Stochastic %K
12%
Beta
0.60
Analysts
Strong Buy
Price target
$113.46

Price

Company profile

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care managemen...

Show more

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Industry
Healthcare Plans
Sector
Healthcare
Phone
401 765 1500
Website
https://www.cvshealth.com
Address
One CVS Drive, Woonsocket, United States

Latest news

Stocktwits

KryptonResearch14 Nov 2, 11:31 AM
$CVS reports Wednesday, and the Aetna improvement in Q2 was not all underlying medical costs. The medical benefit ratio fell to 87.4 percent from 89.9 percent a year earlier, and the 10-Q says part of that was the absence of a 471 million dollar premium deficiency reserve recorded in Group Medicare Advantage last year. The premium mix flipped too. Government premiums rose about 10 percent to 28,494 million dollars while Commercial premiums fell about 20 percent to 6,625 million dollars after the individual exchange exit.
0 replies
Techdamentals Nov 2, 4:35 AM
Sector dispersion runs modestly wider in midterm years, about 11.3% between best and worst against 8.5% normally. That tells you things spread out. It does not tell you which direction any sector goes. $CVS spans pharmacy, insurance and retail, so it rarely moves for one simple reason. Video: https://youtu.be/CrL2GMJ44Gw Written version: https://techdamentals.com/newsletter/what-do-midterms-do-to-the-stock-market?ref=st What is it worth? 👇 https://techdamentals.com/v/CVS?ref=st Educational, not advice.
0 replies
KryptonResearch14 Nov 2, 3:35 AM
$CVS Health Services revenue rose 11.5% in Q2, and the 10-Q channel split shows mail and specialty doing most of the work. Mail and specialty rose 15% to 22,577 million dollars while the pharmacy network rose 8% to 26,617 million dollars, so mail and specialty supplied about 60% of the channel growth even though claims processed were basically flat.
0 replies
GlobalTradersAcademy Nov 1, 9:39 PM
$CVS reports earnings soon, and options traders are bracing for a big move. Whether it beats that number, and in which direction, is what traders will be watching. The stock is down about 3% from a week ago. $SPY $QQQ Worth a read for the key price levels to watch. What's your read on $CVS here? Full story: https://globaltradersacademy.com/articles/cvs-health-earnings-preview-options-traders-brace-for-a-7-2-move?utm_source=stocktwits&utm_medium=social Free 14-day trial: https://globaltradersacademy.com/start-trial?a=stocktwits&sym=CVS&tool=terminal
0 replies
StocktwitsNews Nov 1, 3:58 PM
Mark Cuban Says Public Companies Found They Were ‘Ripped Off’ On Healthcare But Won’t Say So On Earnings Calls $UNH $UNHG $CVS $CI https://stocktwits.com/news/equity/markets/mark-cuban-says-public-companies-found-they-were-ripped-off-on-healthcare-but-won-t-say-so-on-earnings-calls/cNGeHdHR92e
0 replies
TopOptionsAIerts Nov 1, 8:52 AM
$CVS NOV20 93C · still actionable Zone: $89.62 to $90.88 Invalidation: close under $89.55 Objectives: $92.58, then $95.26 The math: up 2.6% to the first objective and 5.6% to the second, against 0.8% risk on the invalidation, better than 7 to 1 to the second. I like this swing because Friday held above $89.55 after a week of selling from $95.26. Earnings land Nov 4, so the Nov 20 expiry gives this room past the report. The zone is tight and the invalidation is clear, so you know where you are wrong before the move starts. If $89.55 holds, $92.58 is the first spot to watch for buyers showing up again.
0 replies
parcha Oct 31, 12:11 PM
https://www.cnbc.com/2026/10/30/jim-cramer-week-ahead-apple-amd-jobs-report.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension $CVS $MCD Wednesday CVS Health reports, and Cramer remains intrigued by the company’s position in the healthcare sector. However, he expressed concerns about its pharmacy benefit management business. “I wish it could disengage with that business; its stock would go higher,” he said. McDonald’s earnings will also be in focus. Cramer wants to see whether the company’s restaurant improvement strategy is gaining traction amid reported concerns from franchisees.
0 replies
TopOptionsAIerts Oct 31, 8:52 AM
$CVS NOV20 94C · still actionable Zone: $89.62 to $90.88 Invalidation: close under $89.55 Objectives: $93.07, then $94.77 The math: up 3.1% to the first objective and 5.0% to the second, against 0.8% risk on the invalidation, better than 6 to 1 to the second. I like this swing because Friday held the $89.55 low after a week of selling from $95.26. Earnings land Nov 4, so the Nov 20 expiry gives this room past the report. You are buying the washout with a line underneath it, not chasing a run. If $89.55 holds, $93.07 is the first spot to watch for buyers showing up again. Watch: $93.07
0 replies